Nephrocare Health Services Limited
Nephrocare Health Services Limited is an Indian listed company in the Healthcare Services industry (Healthcare sector), traded under NSE: NEPHROPLUS and BSE: 544647 (ISIN INE428V01029).
It has a market capitalisation of ₹6,136 crore, a last close of ₹611.55 on 2026-10-19.
Valuation: a price-to-earnings ratio of 79.86x, a price-to-book ratio of 5.50x, a dividend yield of 0.0%.
Profitability: return on equity of 6.9%, return on capital employed of 13.7%, an operating margin of 22.7%.
Balance sheet and ownership: debt-to-equity of 0.07x, promoter holding of 58.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 6,136 |
| Last close | ₹611.55 |
| P/E (TTM) | 79.86x |
| P/B | 5.50x |
| Dividend yield | 0.0% |
| ROE (FY) | 6.9% |
| ROCE (FY) | 13.7% |
| Operating margin (TTM) | 22.7% |
| Debt / equity | 0.07x |
| Promoter holding | 58.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means